Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment.

作者: Dirkjan Van Schaardenburg , Roelf Valkema , Ben A. C. Dijkmans , Socrates Papapoulos , Aeilko H. Zwinderman

DOI: 10.1002/ART.1780380307

关键词: PrednisoneGastroenterologyRheumatoid arthritisRandomized controlled trialChloroquineProspective cohort studyCorticosteroidInternal medicineSurgeryChemotherapyArthritisMedicine

摘要: Objective. Prednisone is frequently used in the treatment of elderly-onset rheumatoid arthritis (RA), but balance between efficacy and toxicity, including effect on bone mass, has not been investigated long-term studies. This prospective, randomized study was undertaken to compare disease activity mass during with prednisone versus chloroquine this patient population. Methods. Patients active RA diagnosed at age ≥ 60 were receive (15 mg/day for 1 month, dosage tapered as low possible thereafter) (n = 28) or 28). who did show a response received other second-line drugs an adjunct replacement chloroquine. Bone measured by dual-energy x-ray absorptiometry. The duration 2 years. Results. During years, needed 12 patients group (43%) 8 (29%). Functional capacity improved significantly both groups differ groups, except greater improvement month. Radiographic scores joint destruction progressed similarly groups. There nonsignificant excess loss 1.8% spine 1.5% hip group, compared group. Conclusion. Neither entirely satisfactory since significant number additional drug over 2-year period.

参考文章(40)
L F Callahan, S B Marcum, T Pincus, Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. The Journal of Rheumatology. ,vol. 19, pp. 1885- 1894 ,(1992)
W. Maksymowych, A.S. Russell, Antimalarials in rheumatology: Efficacy and safety Seminars in Arthritis and Rheumatism. ,vol. 16, pp. 206- 221 ,(1987) , 10.1016/0049-0172(87)90023-0
ERIC S. ORWOLL, SHELIA K. OVIATT, THOMAS MANN, The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. The Journal of Clinical Endocrinology and Metabolism. ,vol. 70, pp. 1202- 1207 ,(1990) , 10.1210/JCEM-70-4-1202
T. H. Ittel, B. K. Koppe, H. G. Sieberth, Differential effect of steroids and chloroquine on the intestinal absorption of aluminium and calcium. Nephrology Dialysis Transplantation. ,vol. 5, pp. 860- 867 ,(1990) , 10.1093/NDT/5.10.860
James F. Fries, Patricia Spitz, R. Guy Kraines, Halsted R. Holman, Measurement of patient outcome in arthritis Arthritis & Rheumatism. ,vol. 23, pp. 137- 145 ,(1980) , 10.1002/ART.1780230202
R. Million, P. Poole, J.H. Kellgren, M.I.V. Jayson, LONG-TERM STUDY OF MANAGEMENT OF RHEUMATOID ARTHRITIS The Lancet. ,vol. 323, pp. 812- 816 ,(1984) , 10.1016/S0140-6736(84)92270-0
R. C. BUTLER, M. W. J. DAVIE, M. WORSFOLD, C. A. SHARP, Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. Rheumatology. ,vol. 30, pp. 86- 90 ,(1991) , 10.1093/RHEUMATOLOGY/30.2.86
Darwin J. Prockop, Sidney Udenfriend, A specific method for the analysis of hydroxyproline in tissues and urine. Analytical Biochemistry. ,vol. 1, pp. 228- 239 ,(1960) , 10.1016/0003-2697(60)90050-6